Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
ecancermedicalscience is Scopus-indexed (Q3, CiteScore 2.1), WoS ESCI, DOAJ. Published by ecancer Global Foundation.
Checked against the index lists dated .
ISSN 1754-6605Verify ISSN ↗
Publisher: ecancer Global Foundation
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 290 / 428 | 32nd | Q3 |
| Cancer Research | 190 / 233 | 18th | Q4 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2009–present (also 2007), best quartile Q3, CiteScore 2.1.
ecancermedicalscience is Q3 in Oncology (rank 290 of 428) and Q4 in Cancer Research (rank 190 of 233), by CiteScore 2025.
ecancermedicalscience is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.1, which places it in quartile Q3 at the 32nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.503, quartile Q3, with an H-index of 54.
The publisher lists an article processing charge of about US$1,226 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
ecancermedicalscience is published by ecancer Global Foundation. Its ISSN is 1754-6605.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
ecancermedicalscience has an h-index of 65 and a 2-year mean of 1.53 citations per paper (OpenAlex). Its Scopus CiteScore is 2.1, quartile Q3. On 2-year citations it ranks #241 of 424 Scopus journals in Oncology.
ecancermedicalscience published 229 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 77 research articles (2026), authors are most often from India (25.6%), United States (6.2%) and Argentina (5.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (0.9 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.